“Company further clarifies that it is in very preliminary stage of exploring avenues and in discussion in synergy between our core activities of pharmaceuticals, cosmeceuticals and nutraceuticals and digital currencies like Bitcoin, Crypto-Currencies, ICO and / or similar products and driving revenues through B2B & B2C channels.”
Market Data 
Markets 
AI
